nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—TAAR1—neck—esophageal cancer	0.0409	0.19	CbGeAlD
Methamphetamine—TAAR1—lung—esophageal cancer	0.0177	0.0823	CbGeAlD
Methamphetamine—SLC18A1—lymph node—esophageal cancer	0.0129	0.0599	CbGeAlD
Methamphetamine—MAOA—neck—esophageal cancer	0.00782	0.0364	CbGeAlD
Methamphetamine—SLC18A2—digestive system—esophageal cancer	0.0072	0.0335	CbGeAlD
Methamphetamine—Benzyl alcohol—ALDH2—esophageal cancer	0.00696	0.231	CrCbGaD
Methamphetamine—SLC22A3—smooth muscle tissue—esophageal cancer	0.00649	0.0302	CbGeAlD
Methamphetamine—MAOB—bronchus—esophageal cancer	0.00614	0.0286	CbGeAlD
Methamphetamine—Dexfenfluramine—CYP2A6—esophageal cancer	0.00607	0.202	CrCbGaD
Methamphetamine—SLC18A2—lung—esophageal cancer	0.00601	0.028	CbGeAlD
Methamphetamine—Lacosamide—CA1—esophageal cancer	0.00528	0.175	CrCbGaD
Methamphetamine—MAOA—bronchus—esophageal cancer	0.00524	0.0244	CbGeAlD
Methamphetamine—ADRA2C—bronchus—esophageal cancer	0.00504	0.0234	CbGeAlD
Methamphetamine—SLC6A4—digestive system—esophageal cancer	0.00499	0.0232	CbGeAlD
Methamphetamine—SLC22A5—bronchus—esophageal cancer	0.00483	0.0224	CbGeAlD
Methamphetamine—MAOB—digestive system—esophageal cancer	0.00474	0.0221	CbGeAlD
Methamphetamine—MAOA—trachea—esophageal cancer	0.0047	0.0219	CbGeAlD
Methamphetamine—SLC6A3—lung—esophageal cancer	0.00455	0.0212	CbGeAlD
Methamphetamine—ADRA2C—trachea—esophageal cancer	0.00452	0.021	CbGeAlD
Methamphetamine—SLC22A5—trachea—esophageal cancer	0.00433	0.0202	CbGeAlD
Methamphetamine—SLC22A3—lung—esophageal cancer	0.00428	0.0199	CbGeAlD
Methamphetamine—SLC6A4—lung—esophageal cancer	0.00417	0.0194	CbGeAlD
Methamphetamine—SLC18A2—lymph node—esophageal cancer	0.00411	0.0191	CbGeAlD
Methamphetamine—MAOA—digestive system—esophageal cancer	0.00405	0.0188	CbGeAlD
Methamphetamine—ADRA2A—bronchus—esophageal cancer	0.00402	0.0187	CbGeAlD
Methamphetamine—Lacosamide—CA2—esophageal cancer	0.004	0.133	CrCbGaD
Methamphetamine—MAOB—lung—esophageal cancer	0.00396	0.0184	CbGeAlD
Methamphetamine—SLC22A5—digestive system—esophageal cancer	0.00373	0.0173	CbGeAlD
Methamphetamine—SLC6A2—lung—esophageal cancer	0.00367	0.0171	CbGeAlD
Methamphetamine—ADRA2A—trachea—esophageal cancer	0.00361	0.0168	CbGeAlD
Methamphetamine—MAOA—lung—esophageal cancer	0.00338	0.0157	CbGeAlD
Methamphetamine—ADRA2C—lung—esophageal cancer	0.00325	0.0151	CbGeAlD
Methamphetamine—SLC22A5—lung—esophageal cancer	0.00311	0.0145	CbGeAlD
Methamphetamine—SLC22A3—lymph node—esophageal cancer	0.00293	0.0136	CbGeAlD
Methamphetamine—MAOB—lymph node—esophageal cancer	0.00271	0.0126	CbGeAlD
Methamphetamine—Selegiline—CYP2A6—esophageal cancer	0.00271	0.0898	CrCbGaD
Methamphetamine—ADRA2A—lung—esophageal cancer	0.00259	0.0121	CbGeAlD
Methamphetamine—SLC6A2—lymph node—esophageal cancer	0.00251	0.0117	CbGeAlD
Methamphetamine—CYP2D6—digestive system—esophageal cancer	0.00241	0.0112	CbGeAlD
Methamphetamine—MAOA—lymph node—esophageal cancer	0.00231	0.0108	CbGeAlD
Methamphetamine—Amphetamine—CYP2A6—esophageal cancer	0.00225	0.0746	CrCbGaD
Methamphetamine—ADRA2C—lymph node—esophageal cancer	0.00222	0.0103	CbGeAlD
Methamphetamine—SLC22A5—lymph node—esophageal cancer	0.00213	0.0099	CbGeAlD
Methamphetamine—Nateglinide—PTGS1—esophageal cancer	0.00185	0.0615	CrCbGaD
Methamphetamine—ADRA2A—lymph node—esophageal cancer	0.00177	0.00825	CbGeAlD
Methamphetamine—Selegiline—ABCB1—esophageal cancer	0.00101	0.0334	CrCbGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GHRL—esophageal cancer	0.000179	0.000238	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PFN1—esophageal cancer	0.000179	0.000237	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CYP19A1—esophageal cancer	0.000179	0.000237	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000177	0.000234	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTT1—esophageal cancer	0.000177	0.000234	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ADH1B—esophageal cancer	0.000176	0.000234	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NOS2—esophageal cancer	0.000175	0.000232	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CYP2A6—esophageal cancer	0.000175	0.000232	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ERBB2—esophageal cancer	0.000174	0.00023	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000174	0.00023	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GAPDH—esophageal cancer	0.000173	0.000229	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FKBP1A—esophageal cancer	0.000172	0.000228	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ELMO1—esophageal cancer	0.000172	0.000228	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CRABP1—esophageal cancer	0.000172	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000169	0.000224	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TYMP—esophageal cancer	0.000169	0.000223	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—CREBBP—esophageal cancer	0.000168	0.000223	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—WIF1—esophageal cancer	0.000168	0.000223	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKAP13—esophageal cancer	0.000168	0.000222	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ENO1—esophageal cancer	0.000166	0.00022	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS1—esophageal cancer	0.000166	0.00022	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL2—esophageal cancer	0.000165	0.000219	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—SST—esophageal cancer	0.000165	0.000218	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000165	0.000218	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP26A1—esophageal cancer	0.000164	0.000217	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PSME1—esophageal cancer	0.000163	0.000216	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PSME2—esophageal cancer	0.000163	0.000216	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GNG7—esophageal cancer	0.000163	0.000216	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—HMOX1—esophageal cancer	0.000163	0.000216	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ELMO1—esophageal cancer	0.000161	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GHRL—esophageal cancer	0.00016	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALOX15—esophageal cancer	0.00016	0.000212	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—CREBBP—esophageal cancer	0.000157	0.000208	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKAP13—esophageal cancer	0.000157	0.000208	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ABCB1—esophageal cancer	0.000156	0.000207	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000155	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000155	0.000205	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000154	0.000204	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000154	0.000204	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000154	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000154	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ANXA1—esophageal cancer	0.000154	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PDE4D—esophageal cancer	0.000154	0.000203	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CCND1—esophageal cancer	0.000154	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALDH2—esophageal cancer	0.000153	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTO1—esophageal cancer	0.000152	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPI1—esophageal cancer	0.000152	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NOS3—esophageal cancer	0.000151	0.0002	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—SST—esophageal cancer	0.00015	0.000198	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CDKN1A—esophageal cancer	0.000149	0.000197	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GNG7—esophageal cancer	0.000146	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALDOB—esophageal cancer	0.000146	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GHRL—esophageal cancer	0.000146	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTT1—esophageal cancer	0.000145	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PFN1—esophageal cancer	0.000145	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000145	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP2A6—esophageal cancer	0.000144	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PDE4D—esophageal cancer	0.000143	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NOS2—esophageal cancer	0.000142	0.000189	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—EP300—esophageal cancer	0.000141	0.000187	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CA2—esophageal cancer	0.000141	0.000187	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CYP1B1—esophageal cancer	0.000141	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NOS3—esophageal cancer	0.000141	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GAPDH—esophageal cancer	0.000141	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CRABP1—esophageal cancer	0.000139	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—XIAP—esophageal cancer	0.000137	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GNG7—esophageal cancer	0.000136	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ENO1—esophageal cancer	0.000136	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS1—esophageal cancer	0.000136	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PSME1—esophageal cancer	0.000134	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PSME2—esophageal cancer	0.000134	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GNG7—esophageal cancer	0.000133	0.000176	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CYP19A1—esophageal cancer	0.000132	0.000176	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000131	0.000174	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000131	0.000174	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ELMO1—esophageal cancer	0.00013	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CTNNA1—esophageal cancer	0.000129	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL2—esophageal cancer	0.000129	0.000171	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—XIAP—esophageal cancer	0.000128	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—CREBBP—esophageal cancer	0.000128	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKAP13—esophageal cancer	0.000127	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000125	0.000165	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALDH2—esophageal cancer	0.000124	0.000165	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CREBBP—esophageal cancer	0.000124	0.000164	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MYC—esophageal cancer	0.000123	0.000163	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000121	0.00016	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—HMOX1—esophageal cancer	0.000121	0.00016	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—EGFR—esophageal cancer	0.00012	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PSME1—esophageal cancer	0.00012	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PSME2—esophageal cancer	0.00012	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL2—esophageal cancer	0.00012	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ANXA1—esophageal cancer	0.00012	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTT1—esophageal cancer	0.000118	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000118	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP2A6—esophageal cancer	0.000117	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDE4D—esophageal cancer	0.000117	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SST—esophageal cancer	0.000116	0.000154	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ABCB1—esophageal cancer	0.000116	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP1B1—esophageal cancer	0.000116	0.000154	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000115	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—EP300—esophageal cancer	0.000115	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NOS3—esophageal cancer	0.000114	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GHRL—esophageal cancer	0.000113	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000113	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PSME2—esophageal cancer	0.000112	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PSME1—esophageal cancer	0.000112	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ANXA1—esophageal cancer	0.000112	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FBXW7—esophageal cancer	0.000112	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNG7—esophageal cancer	0.000111	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ENO1—esophageal cancer	0.000111	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS1—esophageal cancer	0.000111	0.000147	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—NOS3—esophageal cancer	0.000111	0.000147	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TYMP—esophageal cancer	0.00011	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PSME1—esophageal cancer	0.000109	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PSME2—esophageal cancer	0.000109	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP19A1—esophageal cancer	0.000109	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SST—esophageal cancer	0.000109	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—EP300—esophageal cancer	0.000107	0.000142	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000107	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GHRL—esophageal cancer	0.000106	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000106	0.00014	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CREBBP—esophageal cancer	0.000105	0.000139	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PIK3CA—esophageal cancer	0.000105	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FBXW7—esophageal cancer	0.000104	0.000138	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000104	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—XIAP—esophageal cancer	0.000104	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000102	0.000135	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—esophageal cancer	0.000101	0.000134	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—esophageal cancer	0.000101	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HMOX1—esophageal cancer	9.94e-05	0.000132	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPI1—esophageal cancer	9.93e-05	0.000132	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTO1—esophageal cancer	9.93e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CTNNA1—esophageal cancer	9.82e-05	0.00013	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL2—esophageal cancer	9.77e-05	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ABCB1—esophageal cancer	9.55e-05	0.000126	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.52e-05	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH2—esophageal cancer	9.5e-05	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP1B1—esophageal cancer	9.41e-05	0.000125	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NOS3—esophageal cancer	9.36e-05	0.000124	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GAPDH—esophageal cancer	9.16e-05	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PSME2—esophageal cancer	9.12e-05	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PSME1—esophageal cancer	9.12e-05	0.000121	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.08e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ANXA1—esophageal cancer	9.08e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFBR2—esophageal cancer	9.03e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP19A1—esophageal cancer	8.85e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SST—esophageal cancer	8.83e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—EP300—esophageal cancer	8.7e-05	0.000115	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GNG7—esophageal cancer	8.64e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH3—esophageal cancer	8.61e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GHRL—esophageal cancer	8.61e-05	0.000114	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—esophageal cancer	8.56e-05	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SMAD4—esophageal cancer	8.54e-05	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PIK3CA—esophageal cancer	8.49e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FBXW7—esophageal cancer	8.47e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFBR2—esophageal cancer	8.43e-05	0.000112	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—EP300—esophageal cancer	8.42e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—esophageal cancer	8.21e-05	0.000109	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.09e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HMOX1—esophageal cancer	8.08e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SMAD4—esophageal cancer	7.98e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PIK3CA—esophageal cancer	7.93e-05	0.000105	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CREBBP—esophageal cancer	7.76e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ABCB1—esophageal cancer	7.75e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH2—esophageal cancer	7.72e-05	0.000102	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.7e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—esophageal cancer	7.67e-05	0.000102	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.61e-05	0.000101	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ENO1—esophageal cancer	7.22e-05	9.56e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.22e-05	9.56e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—EP300—esophageal cancer	7.12e-05	9.43e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PSME2—esophageal cancer	7.11e-05	9.42e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PSME1—esophageal cancer	7.11e-05	9.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HIF1A—esophageal cancer	6.99e-05	9.26e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—esophageal cancer	6.94e-05	9.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFBR2—esophageal cancer	6.85e-05	9.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KDR—esophageal cancer	6.69e-05	8.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HIF1A—esophageal cancer	6.53e-05	8.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SMAD4—esophageal cancer	6.48e-05	8.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CA—esophageal cancer	6.44e-05	8.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CREBBP—esophageal cancer	6.38e-05	8.45e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—esophageal cancer	6.35e-05	8.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH1—esophageal cancer	6.3e-05	8.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KDR—esophageal cancer	6.25e-05	8.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—esophageal cancer	6.23e-05	8.25e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CA—esophageal cancer	6.23e-05	8.25e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.13e-05	8.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH1—esophageal cancer	5.88e-05	7.79e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.77e-05	7.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—esophageal cancer	5.71e-05	7.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CREBBP—esophageal cancer	5.71e-05	7.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—esophageal cancer	5.61e-05	7.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CA—esophageal cancer	5.36e-05	7.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CREBBP—esophageal cancer	5.33e-05	7.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HIF1A—esophageal cancer	5.3e-05	7.03e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—EP300—esophageal cancer	5.28e-05	7e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CA—esophageal cancer	5.27e-05	6.98e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.26e-05	6.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—esophageal cancer	5.24e-05	6.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—esophageal cancer	5.22e-05	6.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CREBBP—esophageal cancer	5.18e-05	6.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—esophageal cancer	5.11e-05	6.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KDR—esophageal cancer	5.07e-05	6.72e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.05e-05	6.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CA—esophageal cancer	5.01e-05	6.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CA—esophageal cancer	4.87e-05	6.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ERBB2—esophageal cancer	4.78e-05	6.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH1—esophageal cancer	4.78e-05	6.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—esophageal cancer	4.78e-05	6.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—esophageal cancer	4.64e-05	6.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CA—esophageal cancer	4.55e-05	6.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ERBB2—esophageal cancer	4.47e-05	5.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—EP300—esophageal cancer	4.34e-05	5.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	4.33e-05	5.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	4.26e-05	5.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—esophageal cancer	4.24e-05	5.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCND1—esophageal cancer	4.23e-05	5.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1A—esophageal cancer	4.09e-05	5.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	4.07e-05	5.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCND1—esophageal cancer	3.95e-05	5.23e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CA—esophageal cancer	3.91e-05	5.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EP300—esophageal cancer	3.89e-05	5.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	3.88e-05	5.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1A—esophageal cancer	3.82e-05	5.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	3.7e-05	4.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EP300—esophageal cancer	3.63e-05	4.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	3.63e-05	4.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—EP300—esophageal cancer	3.53e-05	4.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—esophageal cancer	3.39e-05	4.49e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.38e-05	4.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—esophageal cancer	3.31e-05	4.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CA—esophageal cancer	3.21e-05	4.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	3.21e-05	4.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—esophageal cancer	3.17e-05	4.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	3.1e-05	4.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—esophageal cancer	3.1e-05	4.1e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—esophageal cancer	3.02e-05	4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	2.95e-05	3.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CA—esophageal cancer	2.88e-05	3.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—esophageal cancer	2.78e-05	3.69e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.76e-05	3.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CA—esophageal cancer	2.69e-05	3.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	2.61e-05	3.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—esophageal cancer	2.6e-05	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	2.57e-05	3.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	2.52e-05	3.33e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—EP300—esophageal cancer	2.3e-05	3.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	2.18e-05	2.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	2.11e-05	2.8e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.7e-05	2.25e-05	CbGpPWpGaD
